Split Creek Capital’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$308K Buy
590
+55
+10% +$28.2K 0.29% 105
2026
Q2
$266K Buy
+535
New +$237K 0.25% 116

Other funds holding VRTX

Split Creek Capital's VRTX Position: Q3 2026 in Review

Split Creek Capital increased its Vertex Pharmaceuticals (VRTX) stake by 10% in Q3 2026, buying an estimated $28.2K and bringing the position to 590 shares worth $308K. The position accounts for 0.29% of the portfolio, ranked #105.

Split Creek Capital first reported a position in VRTX in Q2 2026 and has held it in 2 quarters since. 1,556 funds tracked by Wall St. Rank hold VRTX as of Q3 2026.

  • Split Creek Capital held 590 shares of Vertex Pharmaceuticals worth $308K as of Q3 2026.
  • Split Creek Capital bought 55 Vertex Pharmaceuticals shares in Q3 2026, an estimated $28.2K.
  • Vertex Pharmaceuticals made up 0.29% of Split Creek Capital's portfolio in Q3 2026, its #105 holding.
  • Split Creek Capital first reported a position in Vertex Pharmaceuticals in Q2 2026 and has held it in 2 quarters since.
  • 1,556 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2026.

Based on Split Creek Capital's 13F filing for Q3 2026, filed 2 Nov 2026.